Use of Molecular Imaging to Predict Clinical Outcome in Patients With Rectal Cancer After Preoperative Chemotherapy and Radiation

International Journal of Radiation Oncology Biology Physics

Volumn 74, Issue 1, 2009, Pages 55-59

  Konski, Andre ^a   Li, Tianyu ^a   Sigurdson, Elin ^a   Cohen, Steven J ^a   Small Jr , William ^b   Spies, Stewart ^b   Yu, Jian Q ^a   Wahl, Andrew ^b   Stryker, Steven ^b   Meropol, Neal J ^a  

^a FOX CHASE CANCER CENTER   (United States)

^b NORTHWESTERN UNIVERSITY   (United States)

Author keywords

18 FDG PET scan; Preoperative chemoradiation; Rectal cancer

Indexed keywords

18-FDG PET SCAN; 2-DEOXY-2; BEFORE AND AFTER; CHEMORADIATION; CLINICAL OUTCOMES; COX MODELS; DISEASE-FREE SURVIVALS; FLUORO D GLUCOSE; LOGISTIC REGRESSIONS; MOLECULAR IMAGING; MULTIVARIABLE ANALYSIS; NEOADJUVANT CHEMORADIATION; NEOADJUVANT THERAPIES; NORTHWESTERN UNIVERSITIES; PATHOLOGIC COMPLETE RESPONSES (PCR); POSITRON EMISSIONS; POST TREATMENTS; PRE TREATMENTS; PREOPERATIVE CHEMORADIATION; PROSPECTIVE STUDIES; RECTAL ADENOCARCINOMAS; RECTAL CANCER; RESPONSE PREDICTIONS; SAMPLE SIZES; STANDARDIZED UPTAKE VALUES; STATISTICAL SIGNIFICANCES; TEST RESULTS; UNIVARIATE ANALYSIS;

CHEMOTHERAPY; DIAGNOSTIC RADIOGRAPHY; GLUCOSE; POSITRON ANNIHILATION SPECTROSCOPY; SCANNING; ULTRASONIC IMAGING;

POSITRON EMISSION TOMOGRAPHY;

CAPECITABINE; FLUORODEOXYGLUCOSE F 18; FLUOROURACIL; MITOMYCIN C;

ADVANCED CANCER; ARTICLE; CANCER STAGING; DISEASE FREE SURVIVAL; HUMAN; MAJOR CLINICAL STUDY; MINIMAL RESIDUAL DISEASE; MOLECULAR IMAGING; NONHUMAN; POSITRON EMISSION TOMOGRAPHY; PREDICTION; PREOPERATIVE RADIOTHERAPY; PREOPERATIVE TREATMENT; PRIORITY JOURNAL; RECTUM CARCINOMA; SENSITIVITY AND SPECIFICITY; TREATMENT OUTCOME;

ADENOCARCINOMA; ANALYSIS OF VARIANCE; ANTINEOPLASTIC COMBINED CHEMOTHERAPY PROTOCOLS; DEOXYCYTIDINE; FLUORODEOXYGLUCOSE F18; FLUOROURACIL; HUMANS; MITOMYCIN; NEOADJUVANT THERAPY; POSITRON-EMISSION TOMOGRAPHY; RADIOPHARMACEUTICALS; RECTAL NEOPLASMS; STATISTICS, NONPARAMETRIC;

EID: 64049096718     PISSN: 03603016     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.ijrobp.2008.07.050     Document Type: Article

References (17)

1. Konski A., Hoffman J., Sigurdson E., et al. Can molecular imaging predict response to preoperative chemoradiation in patients with rectal cancer? A Fox Chase Cancer Center prospective experience. Semin Oncol 32 (2005) S63-S67
2. Konski A., Doss M., Milestone B., et al. The integration of 18-fluoro-deoxy-glucose positron emission tomography and endoscopic ultrasound in the treatment-planning process for esophageal carcinoma. Int J Radiat Oncol Biol Phys 61 (2005) 1123-1128
3. McCullagh P., and Nelder J.A. Generalized linear models. 2nd ed. (1989), Chapman & Hall, London
4. Cox D.R. Regression models and life tables. J R Stat Soc 34 (1972) 187-220
5. Snedecor G., and Cochran W.G. Statistical methods. 7th ed. (1980), Iowa State University Press, Ames, IA
6. Calvo F.A., Domper M., Matute R., et al. 18F-FDG positron emission tomography staging and restaging in rectal cancer treated with preoperative chemoradiation. Int J Radiat Oncol Biol Phys 58 (2004) 528-535
7. Wieder H.A., Brucher B.L., Zimmermann F., et al. Time course of tumor metabolic activity during chemoradiotherapy of esophageal squamous cell carcinoma and response to treatment. J Clin Oncol 22 (2004) 900-908
8. Oku S., Nakagawa K., Momose T., et al. FDG-PET after radiotherapy is a good prognostic indicator of rectal cancer. Ann Nucl Med 16 (2002) 409-416
9. Amthauer H., Denecke T., Rau B., et al. Response prediction by FDG-PET after neoadjuvant radiochemotherapy and combined regional hyperthermia of rectal cancer: Correlation with endorectal ultrasound and histopathology. Eur J Nucl Med Mol Imaging 31 (2004) 811-819
10. Denecke T., Rau B., Hoffmann K.T., et al. Comparison of CT, MRI and FDG-PET in response prediction of patients with locally advanced rectal cancer after multimodal preoperative therapy: Is there a benefit in using functional imaging?. Eur Radiol 15 (2005) 1658-1666
11. Guillem J.G., Moore H.G., Akhurst T., et al. Sequential preoperative fluorodeoxyglucose-positron emission tomography assessment of response to preoperative chemoradiation: A means for determining longterm outcomes of rectal cancer. J Am Coll Surg 199 (2004) 1-7
12. Guillem J.G., Puig-La Calle Jr. J., Akhurst T., et al. Prospective assessment of primary rectal cancer response to preoperative radiation and chemotherapy using 18-fluorodeoxyglucose positron emission tomography. Dis Colon Rectum 43 (2000) 18-24
13. Capirci C., Rubello D., Chierichetti F., et al. Restaging after neoadjuvant chemoradiotherapy for rectal adenocarcinoma: Role of F18-FDG PET. Biomed Pharmacother 58 (2004) 451-457
14. Moore H.G., Gittleman A.E., Minsky B.D., et al. Rate of pathologic complete response with increased interval between preoperative combined modality therapy and rectal cancer resection. Dis Colon Rectum 47 (2004) 279-286
15. Habr-Gama A., Perez R.O., Nadalin W., et al. Operative versus nonoperative treatment for stage 0 distal rectal cancer following chemoradiation therapy: Long-term results. Ann Surg 240 (2004) 711-717 discussion 717-718
16. Capirci C., Rubello D., Chierichetti F., et al. Long-term prognostic value of 18F-FDG PET in patients with locally advanced rectal cancer previously treated with neoadjuvant radiochemotherapy. AJR Am J Roentgenol 187 (2006) W202-W208
17. Cascini G.L., Avallone A., Delrio P., et al. 18F-FDG PET is an early predictor of pathologic tumor response to preoperative radiochemotherapy in locally advanced rectal cancer. J Nucl Med 47 (2006) 1241-1248